Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(2.27)
# 2,725
Out of 5,182 analysts
144
Total ratings
45.56%
Success rate
-4.71%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Maintains: In-Line | $12 → $15 | $11.63 | +28.98% | 9 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintains: In-Line | $8 → $5 | $5.27 | -5.12% | 7 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Outperform | $50 → $55 | $44.28 | +24.21% | 2 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Outperform | $90 → $100 | $73.94 | +35.24% | 3 | Feb 25, 2026 | |
| WAY Waystar Holding | Maintains: Outperform | $40 → $27 | $23.74 | +13.73% | 5 | Feb 18, 2026 | |
| HNGE Hinge Health | Maintains: Outperform | $65 → $50 | $38.98 | +28.27% | 3 | Feb 11, 2026 | |
| DGX Quest Diagnostics | Maintains: In-Line | $190 → $220 | $198.02 | +11.10% | 5 | Feb 11, 2026 | |
| ALGN Align Technology | Maintains: Outperform | $180 → $200 | $170.60 | +17.23% | 16 | Feb 5, 2026 | |
| FTRE Fortrea Holdings | Upgrades: Outperform | $14 → $25 | $9.44 | +164.97% | 11 | Jan 6, 2026 | |
| PRVA Privia Health Group | Maintains: Outperform | $28 → $30 | $21.21 | +41.44% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $28 | $12.58 | +122.58% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $81 → $70 | $22.77 | +207.42% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $220 | $214.05 | +2.78% | 10 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $95 | $73.49 | +29.27% | 10 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $220 → $240 | $173.26 | +38.52% | 7 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4 → $3 | $1.17 | +156.41% | 9 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $305 | $273.72 | +11.43% | 7 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $800 → $825 | $884.28 | -6.70% | 7 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $23 | $25.81 | -10.89% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $125 → $75 | $10.74 | +598.32% | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $68 → $26 | $1.28 | +1,958.82% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $35 → $15 | $1.26 | +1,090.48% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $11 | $0.60 | +1,718.78% | 2 | Jan 4, 2022 |
DENTSPLY SIRONA
Feb 27, 2026
Maintains: In-Line
Price Target: $12 → $15
Current: $11.63
Upside: +28.98%
Teladoc Health
Feb 26, 2026
Maintains: In-Line
Price Target: $8 → $5
Current: $5.27
Upside: -5.12%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $50 → $55
Current: $44.28
Upside: +24.21%
Henry Schein
Feb 25, 2026
Maintains: Outperform
Price Target: $90 → $100
Current: $73.94
Upside: +35.24%
Waystar Holding
Feb 18, 2026
Maintains: Outperform
Price Target: $40 → $27
Current: $23.74
Upside: +13.73%
Hinge Health
Feb 11, 2026
Maintains: Outperform
Price Target: $65 → $50
Current: $38.98
Upside: +28.27%
Quest Diagnostics
Feb 11, 2026
Maintains: In-Line
Price Target: $190 → $220
Current: $198.02
Upside: +11.10%
Align Technology
Feb 5, 2026
Maintains: Outperform
Price Target: $180 → $200
Current: $170.60
Upside: +17.23%
Fortrea Holdings
Jan 6, 2026
Upgrades: Outperform
Price Target: $14 → $25
Current: $9.44
Upside: +164.97%
Privia Health Group
Nov 7, 2025
Maintains: Outperform
Price Target: $28 → $30
Current: $21.21
Upside: +41.44%
Nov 7, 2025
Maintains: Outperform
Price Target: $27 → $28
Current: $12.58
Upside: +122.58%
Nov 7, 2025
Maintains: Outperform
Price Target: $81 → $70
Current: $22.77
Upside: +207.42%
Oct 31, 2025
Maintains: Outperform
Price Target: $190 → $220
Current: $214.05
Upside: +2.78%
Oct 30, 2025
Maintains: Outperform
Price Target: $85 → $95
Current: $73.49
Upside: +29.27%
Oct 8, 2025
Maintains: Outperform
Price Target: $220 → $240
Current: $173.26
Upside: +38.52%
Oct 8, 2025
Maintains: In-Line
Price Target: $4 → $3
Current: $1.17
Upside: +156.41%
Oct 3, 2025
Maintains: Outperform
Price Target: $300 → $305
Current: $273.72
Upside: +11.43%
Sep 24, 2025
Maintains: Outperform
Price Target: $800 → $825
Current: $884.28
Upside: -6.70%
Jul 9, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $25.81
Upside: -10.89%
Jul 9, 2025
Maintains: In-Line
Price Target: $125 → $75
Current: $10.74
Upside: +598.32%
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $1.28
Upside: +1,958.82%
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $1.26
Upside: +1,090.48%
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $0.60
Upside: +1,718.78%